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Abstract
Intra-host evolution of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) has been shown by
viral RNA analysis in subjects who naturally suppress plasma viremia to low levels, known as controllers. However, little is
known about the variability of proviral DNA and the inter-relationships among contained systemic viremia, rate of reservoir
reseeding and specific major histocompatibility complex (MHC) genotypes, in controllers. Here, we analysed the proviral DNA
quasispecies of the env V1-V2 region, in PBMCs and in anatomical compartments of 13 long-term controller monkeys after
3.2 years of infection with simian/human immunodeficiency virus (SHIV)SF162P4cy. A considerable variation in the genetic
diversity of proviral quasispecies was present among animals. Seven monkeys exhibited env V1-V2 proviral populations
composed of both clusters of identical ancestral sequences and new variants, whereas the other six monkeys displayed
relatively high env V1-V2 genetic diversity with a large proportion of diverse novel sequences. Our results demonstrate that
in SHIVSF162P4cy-infected monkeys there exists a disparate pattern of intra-host viral diversity and that reseeding of the
proviral reservoir occurs in some animals. Moreover, even though no particular association has been observed between MHC
haplotypes and the long-term control of infection, a remarkably similar pattern of intra-host viral diversity and divergence
was found within animals carrying the M3 haplotype. This suggests that in animals bearing the same MHC haplotype and
infected with the same virus, viral diversity follows a similar pattern with similar outcomes and control of infection.
INTRODUCTION
Simian/human immunodeficiency virus (SHIV) infection in
nonhuman primates (NHPs) has proven invaluable in pro-
viding insights into human immunodeficiency virus-1
(HIV-1) pathogenesis and for intervention studies [1]. Pre-
clinical studies on different monkey species have indicated
that a differential susceptibility to primate lentivirus-
induced diseases could be related to the genetic diversity of
the animals [2–6]. SHIVSF162 is a C-C chemokine receptor
type 5 (CCR5)-tropic virus capable of establishing persistent
infection and causing simian acquired immune deficiency
syndrome (AIDS) with a varying disease progression that is
characteristic of HIV disease in humans [2, 7]. Rhesus mac-
aques can be readily infected with SHIVSF162 viral isolates,
while cynomolgus macaques are more resistant to infection,
consistent with the evidence of host factors that affect spe-
cies-level differences in infection susceptibility and disease
progression [8]. In cynomolgus monkeys, the acute phase of
infection is followed by a prolonged asymptomatic phase, in
which monkeys can efficiently control viral replication,
maintaining it at very low levels during chronic infection in
the absence of treatment, similar to HIV-infected humans
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who control infection and become long-term nonprogres-
sors (LTNPs).
Despite control of viremia, human HIV controllers present
ongoing evolution and divergence of viral RNA sequences,
although at a significantly lower rate than that observed for
typical progressors [9]. In contrast, the DNA proviral popu-
lation is highly homogenous, mostly composed of ancestral
sequences, suggesting that in these individuals ongoing rep-
lication does not permit the significant reseeding of the
latent reservoir [10]. However, given the ability of HIV and
SIV to establish a stable latent viral reservoir in anatomic
sites early in infection, viral replication might persist in tis-
sues; this is the case where immune responses developed by
controllers fail to eradicate HIV/SIV infections [11]. Recent
data suggest that latent reservoirs may be established before
virus can be detected in the peripheral blood, making it dif-
ficult to treat HIV-1 early enough to avoid reservoir seeding.
Latently infected cells remain undetectable by the immune
system and can persist for years without losing their ability
to produce infectious virus [10, 12]. There are conflicting
data on whether new virus variants emerge in distinct ana-
tomic sites by restriction of viral gene flow, with consequent
viral evolution and divergence from virus present in the
blood, or they disseminate to other anatomic sites through
ongoing replication [13]. Thus, virus genetic variations
across the body might provide insights to understand the
potential correlation between suppression of viral replica-
tion and rate of reservoir reseeding in controllers.
Control of systemic viral suppression levels has been corre-
lated with particular MHC class I alleles, such as human leu-
kocyte antigen (HLA)-B27, B57 in humans, or Macaca
mulatta (Mamu)-B17 and Mamu-B08 in macaques,
although specific genotypes are only associated with, and
not predictive of viral control [14–16]. The role of monkey
models has been crucial for the elucidation of the mecha-
nisms that underlie control of virus replication because the
viral strain, host genotype as well as timing and route of
infection can be controlled [17–22]. Furthermore, animal
models enable extensive tissue collection at necropsy, facili-
tating studies of viral reservoirs and evaluation of virus vari-
ability [23–26].
In our previous work, we showed the effects of MHC haplo-
types on early and late SHIVSF162P4cy infection in Mauritian
cynomolgus macaques (MCM), highlighting the importance
of considering host-related genetic background and immu-
nological factors in the evaluation of vaccine efficacy in the
different monkey species [20, 21].
Here, we describe the proviral DNA quasispecies diversity
and phylogenetic relationships among proviral variants at
the env V1-V2 region, in the peripheral blood and in
lymphoid, gastrointestinal (GI) and genital anatomical com-
partments, of 13 long-term controller SHIVSF162P4cy-
infected MCM with defined MHC haplotypes. The pattern
of changes of SHIVSF162P4cy DNA populations in the setting
of long-term undetectable viremia over 170weeks and the
association with putative restrictive MHC alleles were also
investigated.
RESULTS
A cohort of 13 monkeys experimentally infected with
SHIVSF162P4cy was followed for 3.2 years.
LNTPs were defined as monkeys surviving SHIVSF162P4cy
infection more than 2 years post infection (p.i.) and having
plasma viral RNA copies below the detection limit (<50 cop-
iesml 1). In this cohort, all animals had stable CD4+ T and
CD8+ T cell numbers; from week 46 they remained plasma
RNA-negative throughout the period of observation of
170weeks (data not shown), and no animal had signs of dis-
ease development.
Antibody response kinetics showed that all animals
mounted robust anti-Env binding antibody (bAb) responses
with peak titres ranging between 1 : 800 and 1 : 25600, which
declined by week 170 p.i. in 9 of 13 animals. The remaining
four monkeys maintained detectable anti-Env bAb through-
out this period of time. Similarly, at 170weeks p.i., neutral-
izing Ab (nAb) titres diminished or became undetectable
in all but three animals, which had persistent
homologous nAbs.
For detection and quantification of viral DNA in the lym-
phoid, GI and genital anatomic locations of viral-suppressed
animals at 170 weeks p.i., quantitative PCR assays targeting
the gag gene were performed.
As shown in Table 1, low levels of proviral DNA were
detected in PBMC (<1 to 11 copies µg-1) whereas in tissues,
the virus was most prominent in the GI jejunum/ileum tract
(2 to 152 copies µg-1). Lower levels of viral DNA were
detected in lymphoid tissues such as axillary lymph nodes,
inguinal lymph nodes, spleen (2 to 112 copies µg-1) and gen-
ital tissues including epididymis, testis, prostate, penis, rec-
tum (2 to 48 copies µg-1), with epididymis (P=0.0191) and
testis (P=0.0302) displaying higher levels of viral DNA com-
pared to prostate (Fig. 1a). The low level of viral DNA mea-
sured in the tissues may be due, at least in part, to a
relatively low frequency of target cells (CD4+ T; macro-
phages) in the tissue specimens [23, 25]. Interestingly, sta-
tistical analysis demonstrated a positive (relatively weak)
correlation between genital viral DNA levels at necropsy
and both acute phase plasma viremia (P=0.0485), (Fig. 1b),
and the area under the curve (AUC) of the RNA levels over
170weeks p.i., a parameter reflecting cumulative plasma
virus production (P=0.0492) (Fig. 1c).
Analyses of env V1-V2 sequence diversity in
SHIVSF162P4cy controllers
For each animal, the mean Env diversity from the parental
clone was calculated by pairwise comparisons and repre-
sents the average viral changes emerging after infection.
According to the degree of diversity of env V1-V2 variants
identified, we clustered animals into four different groups,
revealing that both diversity and complexity of virus
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quasispecies varied extensively among animals (Table 2). In
group 1, the pattern observed in monkeys AU676, AQ271,
AQ882, AG172, AS377, AK484 and AU427 was character-
ized by low genetic diversity as compared to the challenge
virus. The mean genetic distances between SHIVSF162P4cy
and PBMC at week 2 or week 170 p.i. ranged from 0.004 to
0.017 and from 0.001 to 0.061, respectively, whereas the
overall mean pairwise distances from the inoculum, among
tissue compartments, ranged from 0 to 0.075, with the
exception of animal AS377, which exhibited higher genetic
distances (0–0.295). This result indicated that in periphery
and in the tissue compartments, the V1-V2 variants were
composed mainly of ancestral sequences and some novel
variants, which were widely disseminated during acute
phase.
Group 2 monkeys (AS167, AH694 and AG981) displayed
high levels of V1-V2 viral diversity (range, 0.006–0.310)
with PBMC variants isolated at week 2 p.i. exhibiting a
genetic distance ranging from 0.298 to 0.310. In contrast at
170weeks p.i., quasispecies were more similar to those of
the challenge virus, with a genetic distance ranging from
0.006 to 0.054. Despite the long-term follow up, quasispecies
in the tissue compartments were similar to those of PBMC
sampled at week 2 p.i. (genetic distance ranging from 0.006
to 0.041) but divergent from those of the challenge virus
(range, 0.292–0.323). This finding indicated that V1-V2 var-
iants present across tissues at necropsy were probably estab-
lished during acute phase by spreading of viral variants
arising early in infection.
Group 3 comprised two animals, AH960 and AK952. Here,
V1-V2 quasispecies in the tissue compartments showed low
diversity compared to those of week 2 PBMC and
SHIVSF162P4cy, (range 0.002–0.011), suggesting that they
were derived from infected cell populations that had spread
across tissues early in infection. In contrast, the high genetic
diversity of week 170 PBMC variants (range, 0.187–0.414)
indicated, most likely, a blood re-seeding from anatomic
compartments, which were not investigated in this study.
Finally, group 4 comprised a single monkey, AP511, and
was characterized by high diversity of week 2 PBMC var-
iants as compared to SHIVSF162P4cy (0.29), whereas at
170weeks, the V1-V2 proviral populations in both PBMC
(0.077) and tissue (0.01) were quite homogeneous.
Overall these data show that a high viral diversity existed
among infected animals. Moreover, virus challenge dose
had no impact on the viral diversity at early and late time
points of infection, since monkeys infected with low
(1.79MID50) or high (179MID50) infectious doses showed
comparable env V1-V2 diversity (0.03), which is supportive
of our previous results [20, 21].
Phylogenetic analysis of env V1-V2 proviral
quasispecies in SHIVSF162P4cy controllers
The phylogenetic relationship between env V1-V2 proviral
quasispecies in the tissue compartments and those in the
PBMC sampled at week 2 or 170 p.i. was assessed. A neigh-
bour-joining (NJ) phylogenetic tree was generated initially
to investigate the clustering of sequences within and
between anatomic sites and PBMC. The potential genetic
segregation of V1-V2 quasispecies between PBMC and ana-
tomical compartments was confirmed by applying the Slat-
kin–Maddison test; this analysis can estimate and
statistically measure the viral in/out gene flow between
compartments.
Phylogenetic analysis identified three clades (A, B and C).
Most of the V1-V2 sequences clustered into clade B and
were closely related both to the SHIVSF162P4cy inoculum and
to the reference sequence (accession number JN205735)
(Figs 2 and S1–S3, available in the online version of this
article). Specifically, 10 out of 13 macaque quasispecies
Fig. 1. Proviral load in tissue compartments and correlation between virological parameters in infected monkeys. SHIVSF162P4cy DNA
viral load in epididymis, testicle, prostate and penis of infected macaques, by quantitative real-time PCR. Mean in each group is repre-
sented by black bars. Stars indicate statistical difference between organs with epididymis (P=0.0191) and testis (P=0.0302) displaying
the higher levels of viral DNA as compared to prostate (a). The amount of proviral DNA detected in each of the genital tissues for each
animal was plotted against the acute phase plasma viremia level for all animals (P=0.0485) (b). The amount of proviral DNA detected
in each of the genital tissues for each animal was plotted against the area under the curve (AUC) of plasma viremia between weeks
1–170 p.i. (P=0.0492) (c).
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located on clade B were intermixed, suggesting that in each
monkey there has been an exchange of variants between
periphery and tissue compartments, with the exception of
week 170 PBMC variants of some animals that clustered on
distinct branches, namely on clade C or externally to the
clades.
This result was supported by the Slatkin–Maddison test that
determined in each monkey statistically significant gene
flows from week 170 PBMC variants to genital (range 20%),
gastrointestinal (range 50%) and lymphoid tissues (range
50%), and indicated a lack of anatomical compartmentali-
zation. Interestingly, within the B clade five, statistically sig-
nificant partially segregated sub-clusters, from 4 to 8, were
identified indicating weak compartmentalization of quasis-
pecies sustained by gene flow analysis.
In contrast, clade A included most of the V1-V2 sequences
from macaques AS167, AH694, AG981 and week 2 PBMC
variants of monkey AP511 (clade A, 100% bootstrap value).
In animals AS167, AH694 and AG981, tissue quasispecies
genetically distant from the virus inoculum, clustered
together with week 2 PBMC variants. This suggested that
the population of quasispecies present in the acute phase
persisted in the tissues over 170weeks of infection, as clearly
shown by sub-cluster 3 present in week 2 PBMC and tissue
variants of monkey AG981. In contrast, in the same ani-
mals, PBMC variants present at weeks 170 p.i. were located
on clade B and mostly related to the virus inoculum. This
result pointed at a compartmentalization between blood
and tissue at 170weeks p.i., and a possible reseeding of the
PBMC variants by reservoir from other anatomical sources.
The Slatkin–Maddison analysis confirmed the absence of
gene flow from/to PBMC and anatomical compartments at
170weeks p.i.
Finally, clade C included V1-V2 variants derived from mon-
key AK484 epididymis and from week 170 PBMC of mon-
key AH960 and AK952. In monkey AH960, we observed
statistically supported phylogenetic evidence of
compartmentalization of PBMC and tissue quasispecies at
week 170 p.i.
Analysis of single-site mutations
Analysis of the sequence alignment of all monkey quasispe-
cies of SHIVSF162P4cy, performed by Highlighter analysis,
identified mutations shared across the animal variants
(identical sequences were not included in the analysis) (Fig.
S4). The majority of virus variants carried substitutions at
eight codons: four at the amino acids K134, N135, A136,
D148; two at the potential PNG sites K140, K158 in V1
region and two at amino acids R164 and K190 in the V2
region (Table S1). These variations appeared late in infec-
tion and simultaneously in blood cells and tissues, except
for R164K/G changes that were found in both anatomical
compartments either at weeks 2 and 170 p.i., suggesting a
substantial amount of viral variant migrations, as already
described.
Six out of eight substitutions detected in the env V1-V2
region of the viral variants have been previously reported by
Balfe et al., [27] in the SHIVSF162P3 isolate that they termed
the signature of the P3 variant. This signature made the V1-
V2 regions of the long-term infected monkeys more like
V1-V2 regions of SHIVSF162P3 than those of the inoculum
virus SHIVSF162P4cy or SHIVSF162P4. This tendency was
common to all macaques, suggesting that the same selection
pressure drove the changes. As both SHIVSF162P4cy and
SHIVSF162P4 viruses were obtained from in vivo passage of
SHIVSF162P3, it is also possible but speculative that, in the
absence of selective pressure upon transmission of
SHIVSF162P4cy to a new host, the mutations were lost and
reverted to SHIVSF162P3 thereby conferring a fitness advan-
tage to the virus during long-term infection. Overall, even if
viral populations diverged to different levels in different ani-
mals, reversion by de novo mutation after passage to MHC-
disparate hosts can occur, likely due to the absence of CTL
response against specific epitopes.
Table 1. Load of proviral DNA (copie g 1) in PBMC and tissues at necropsy (week 170)
AS167 AH960 AS377 AU427 AP511 AG172 AH694 AU676 AQ882 AK484 AK952 AQ271 AG981
PBMC <1 3 <1 5 <1 7 3 <1 <1 <1 4 11 <1
Axillary LN 17 13 8 8 NA <1 NA 59 8 10 1 1 10
Inguinal LN 42 0 2 4 NA NA 11 <1 9 116 NA 0 28
Spleen <1 <1 3 15 <1 8 16 17 <1 11 16 18 <1
Jejunum <1 2 36 5 <1 6 1 13 <1 28 102 <1 7
Ileum 3 NA 2 7 20 NA 72 61 152 52 20 <1 5
Epididymis NA 5 NA 29 29 <1 28 NA NA 12 5 NA NA
Testis 48 4 5 <1 3 9 6 36 14 7 15 NA NA
Prostate 5 <1 <1 10 <1 <1 3 2 <1 <1 <1 <1 2
Penis 5 11 <1 <1 <1 NA 15 <1 <1 NA 8 2 NA
Rectum 2 NA 5 <1 <1 NA 3 23 <1 <1 NA 7 NA
All values are the means for five different tissue samples of each tissue. NA, not available due to lack of tissue or due to low detectable viral DNA
Capone et al., Journal of General Virology 2018;99:1717–1728
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Increase of predicted glycans in monkeys with
divergent env V1-V2 regions
To evaluate the glycosylation pattern of the viral variants in
animal tissues and PBMC of controller monkeys, we sought
differences in the number of potential N-linked glycosyla-
tion (PNLG) sites of env V1-V2 regions using the N-Glyco-
Site tool (reference strain, accession number JN205735)
[28]. There was no difference in the lengths of V1-V2
sequences (P=0.30) and only a moderate variation in the
total number of PNLG among compartments as compared
to the virus inoculum; however there were no significant
trends overall. By contrast, there was a difference in total
PNLG changes, when the sequences were grouped accord-
ing to clade A (7 macaques/134 sequences), clade B (13
macaques/351 sequences) or clade C (3 macaques/15
sequences), with 57 PNLG site changes that occurred in
clade A as compared to 21 in clade B and 55 in clade
C. More specifically, statistical analysis showed that in clade
B a low number of PNLG changes (19 lost/4 acquired)
occurred, as compared to clade A (13 lost/44 acquired) and
clade C (20 lost/35 acquired), respectively. According to the
genetic divergence levels, while the number of PNLG in low
divergent sequences remained relatively conserved (clade
B), more divergent sequences included in clade A had a gain
of PNLG sites as compared to clade B (P=0.0472) (Fig. 3b),
whereas in clade C sequences showed both loss and acquisi-
tion of new PNLG sites as compared to both clade A
(P=0.0012; P=0.0001) and B (P=0.0004; P=0.0001), respec-
tively (Fig. 3a, b). In particular a Lys-to-Asn change at posi-
tion 158 (K158N) in V2 region (clade A and C), encoding a
novel glycosylation site involved in the neutralizing
antibody responses, was absent in blood cells early in infec-
tion but appeared at week 170 p.i. in both blood and tissue
compartments (P=0.0475) (Fig. 3c).
Effects of MHC haplotype on viral diversity
In humans, HLA genotypes HLA-B57 and HLA-B27 are
associated with slow HIV disease progression [29]. Likewise
alleles Mamu-A01, Mamu-B08, Mamu-B17 in rhesus maca-
ques, or haplotypes M3 and M6 in cynomolgus monkeys,
are associated with superior control of SIV or SHIV infec-
tion [15, 17–22]. To evaluate the influence of MHC haplo-
type on the outcome of long-term infection, animals were
arranged into four groups, each containing three animals
heterozygous for M1 (AH694, AQ271, AU427), M3 (AS167,
AK484, AG981), M4 (AH960, AK952, AU427) or M7
(AU676, AQ882, AP511) haplotype (Table S2). For statisti-
cal analysis, monkey AU427 with M1/M4 haplotype was
included in both M1 and M4 groups, whereas recombinant
haplotypes (monkey AG172) and the only M5 haplotype
(monkey AS377) were excluded.
No statistically significant haplotype advantage was
observed in terms of provirus copy numbers, CD4 T-cell
counts and anti-Env Ab response on long-term control of
viral infection, likely due to the small number of animals
(data not shown).
In contrast, sequence diversity differed significantly between
either MHC haplotype or within the same group. As shown
in Table 3, the mean genetic distances among variants with
SHIVSF162P4cy inoculum ranged from 0.023 in M7 to 0.183
in M3 haplotype, and within variants of the same group
Table 2. Mean genetic distances among SHIVSF162P4cy DNA variants in PBMC and tissue compartments of long-term infected monkeys
Group Monkeys Proviral diversitya from SHIVSF162P4cy Tissue compartment proviral diversity
a from virus inoculum and PBMC
PBMC week 2 PBMC week 170 SHIV
SF162P4cy
PBMC week 2 PBMC week 170 S.E.
1 AU676 0.004 S.E. 0.004 0.005 S.E.0.002 0–0.007 0.002–0.006 0.005–0.012 <0.005
AQ271 0.006 S.E. 0.003 0.022 S.E. 0.011 0–0.009 0.006–0.016 0.022–0.032 <0.007
AQ882 0.006 S.E. 000.2 0.009 S.E. 0.007 0.001–0.007 0.006–0.013 0.010–0.017 <0.005
AG172 0.010 S.E. 000.4 0.047 S.E. 0.009 0–0.007 0.010–0.015 0.047–0.056 <0.010
AS377 0.012 S.E. 0.006 0.061 S.E. 0.016 0–0.295 0.009–0.296 0.061–0.075 <0.007
AK484 0.017 S.E. 0.007 0.001 S.E. 0.001 0–0.008 0.014–0.023 0.001–0.009 <0.005
AU427 0.017 S.E. 000.7 0.001 S.E. 0.001 0–0.007 0.015–0.023 0.001–0.008 <0.007
2 AS167 0.298 S.E. 0.056 0.054 S.E.0.010 0.3–0.318 0.009–0.061 0.355–0.374 <0.014
AH694 0.303 S.E. 0.052 0.013 S.E. 0.005 0.295–0.303 0.006–0.012 0.312–0.320 <0.003
AG981 0.310 S.E.0.053 0.006 S.E. 0.005 0.292–0.323 0.014–0.041 0.297–0.328 <0.013
3 AH960 0.007 S.E. 0.003 0.189 S.E. 0.003 0–0.005 0.007–0.012 0.187–0.19 <0.003
AK952 0.006 S.E. 0.003 0.410 S.E. 0.074 0.002 0.008 0.414 <0.003
4 AP511 0.291 S.E. 0.052 0.077 S.E. 0.017 0–0.011 0.291–0.299 0.077–0.088 <0.005
a, mean intrasample genetic distance of viral sequences analysed at week 2 and week 170 p.i.
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from 0.040 in M7 to 0.183 in M3 haplotype. This difference
was substantial for M3, with about 8, 5.5 and 2.6 times the
distance from SHIVSF162P4cy and nearly 4.5, 3 and 1.6 times
the distance within the same haplotype from M7, M4 and
M1. After all, according to the diversity level of env V1-V2
variants, two out of three M3 animals were included in the
second group of genetic diversity displaying higher levels of
viral diversity (see Table 2)
Most of the sequences of M3 macaques segregated to clade
A. With the exception of the epididymis sequences of mon-
key AK484 and week 170 PBMC of animal AH960 and
AK952 located on clade C, all of the other sequences were
included on clade B. Although the observation regarding
changes that emerged after infection was not statistically
significant due to the small number of animals, each group
of animals harboured specific amino acid changes.
Mutation K158N was observed almost exclusively in tissue
variants of M3 animals. However only a trend toward statis-
tical significance was noted for the presence of this mutation
in M3 as compared to M1 and M4 haplotypes (P=0.0518)
(data not shown). Conversely, a change at residue R164 in
V1 was recurring in 90% of monkey tissues, with the excep-
tion of the week 170 PBMC of monkeys with M3 and M4
haplotypes. Tissues of M1, M3 and M4 animals, as well as
week 170 PBMC of M4- and M7-positive monkeys, carried
a mutation at amino acid 190 in V2 with the number of
changes per sequence significantly greater in tissues of M3-
as compared to M7-positive monkeys (P=0.0482) (data not
shown). Thus, at least for K158 and K190, the M3 haplotype
was associated with a signature in tissues when compared to
the other haplotypes. Considering that M1 and M3 haplo-
types share the same class IA alleles, it is possible that in
animals bearing M3 haplotype, class I B alleles can influence
virus diversity.
It was of interest to analyse whether the total number of
PNLG sites in variants of different haplotypes increased
over time and/or was related to env V1-V2 diversity. Based
on diversity levels of V1-V2 regions, analysis of M3- and
M4-animal sequences revealed a gain of PNLG sites. In par-
ticular, statistical analysis showed that M4 haplotype var-
iants from week 170 PBMC had an increase of PNLG sites
as compared to M1 (P=0.0018), M3 (P=0.0002), M7
(P=0.0004) (Fig. 3d). These data suggest that haplotype-
dependent mechanisms may be involved in the generation
of major V1-V2 viral variants during chronic infection.
DISCUSSION
In HIV controllers the proviral population is extremely
homogeneous with no divergence over time and the major-
ity of PBMC-associated proviral sequences represent ances-
tral variants without sequence replenishment from viruses
in plasma [13, 30, 31]. Recently it has been demonstrated
that PBMC proviral reservoir reseeding in HIV controllers
can be possible from sanctuary tissue sites [13]. However,
studies are needed to determine whether HIV-1 is broadly
distributed or compartmentalized across tissues. Obtaining
human samples for testing is difficult, however the macaque
model of infection facilitates extensive tissue collection and
detailed analyses of viral populations in blood and tissues.
In this study of long-term controller monkeys, we generated
phylogenetic evidence for high proviral genetic diversity at
the env V1-V2 regions in PBMC and lymphoid, gastrointes-
tinal and genital compartments over a period of approxi-
mately 3 years. Two distinct patterns of intra-host viral
diversity were observed. Seven animals (AU676, AQ271,
AQ882, AG172, AS377, AK484 and AU427) displayed
homogeneous proviral populations (<1% diversity) mainly
composed of large clusters of identical sequences. In con-
trast, the other six animals (AS167, AH694 AG981, AH960,
AK952, AP511) showed greater diversity in their quasispe-
cies (>3%), comprising both clusters of identical and unique
sequences, similar to long-term controllers with detectable
plasma viremia [13, 30]; these were difficult to directly cor-
relate in animals with viral suppression. However, a exami-
nation of the quasispecies diversity revealed a more
complex picture. As described in Results, four different
groups, according to the diversity levels of env V1-V2 var-
iants, were identified. PBMC and tissue-associated V1-V2
sequences in group 1 animals showed no or minimal diver-
gence over time, with the possibility that ancestral variants
persisted for more than 3 years of infection, potentially
resulting from clonal expansion of CD4+ T lymphocytes as
the substantial reservoir. In contrast, a different scenario
appeared within group 2 macaques. In these animals, the
levels of env V1-V2 diversity detected in PBMC at week
2 p.i. and in tissues compartments, were much higher than
those estimated for proviral PBMC at week 170 p.i. This
result is consistent with an infection of blood cells during
acute phase with variants highly divergent from challenge
virus, followed by wide dissemination and compartmentali-
zation in anatomical sites. Conversely, the low genetic
divergence of week 170 PBMC variants, can be explained by
a re-seeding of the PBMC proviral reservoir from compart-
ments, for example B cell follicles or brain, that were not
investigated in this study. In sharp contrast, in group 3
monkeys, env V1-V2 proviral populations in tissues at nec-
ropsy were genetically distant from those in PBMC at the
same time point, suggesting the existence of ongoing viral
replication in other anatomical compartments as previously
described [32].
Examination of sequence polymorphisms highlighted that
within individual hosts over time and in relation to the virus
inoculum, several common changes led to an ancestral
sequence, in this case SHIVSF162P3, suggesting that the virus
recovers ancestral features upon transmission to the new
host. Some changes arose faster than others, with the most
rapid mutations arising within structurally conserved resi-
dues, such as that at codon 164 that lies within the V2 loop,
and which is known to harbour neutralizing antibody epito-
pes. Another change leading to a glycan insertion was found
at codon 158 of virus in several animals, suggesting that
probably the same selection pressure was driving this
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mutation. Neutralization escape of HIV/SIV has been previ-
ously associated with a high number of glycosylation sites
and deletions in the external regions of the Env protein
[33]. Since N158 has been described in a rhesus macaque as
an escape mutant from autologous immune recognition at
week 6 p.i. [27], it is suggested that in the monkeys investi-
gated the same driving force has induced the N158 mutation
in the early stage of infection, maintaining the phenotype
both in blood and tissues over 170 weeks, as proviral DNA
has an extremely long half-life and can persist for years.
Fig. 2. Phylogenetic analysis of env V1-V2 sequences from 13 SHIVSF162P4cy controller monkeys. The neighbour-joining (NJ) tree was
rooted by the midpoint rooting. The consensus of the inoculum and the reference sequence (JN205735) were indicated by a blue
arrow. The scale bar at the bottom of the tree indicated 0.04 nucleotide substitutions per site. One asterisk (*) along the branches rep-
resents significant statistical support for the clusters subtending that branch (bootstrap support >75%). Main clades were highlighted.
The compartments have been indicated by different colours (genital: red; gastro enteric: green; lymphoid: blue; peripheral blood mono-
nuclear cells (PBMC) week 2 p.i.: black; PBMC week 170 p.i.: yellow). Tissues are indicated as follow: LIN, Axillar lymph node; LING,
inguinal lymph node; M, spleen; TES, testicle; RE, rectum; EPI, epididymis; PRO, prostate; DIG, jejunum; IL, ileum; PBMC, week 2 p.i.,
PBMCS, week 170 p.i. Monkey IDs correspond to progressive numbers from 1 to 13 (AU676=1; AQ271=2; AQ882=3; AG172=4;
AS377=5; AK484=6; AU427=7; AS167=8; AH694=9; AG981=10; AH960=11; AK952=12; AP511=13).
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Quasispecies represent a compromise between evasion from
the host immune response and lower ability of replication,
thus recovery of an ancestral state may reflect restoration of
virus fitness that was lost as a result of immunological
escape in the previous host and important for viral replica-
tion. In this setting, in long-term controller monkeys
infected with the same virus stock, the divergent patterns of
genetic diversity of env V1-V2 proviral populations may be
due to different control mechanisms of viral replication or
to more effective SHIVSF162P4cy-specific immune responses.
Usually escape mutations lead to lower replicative viral fit-
ness and, in the absence of immune pressure, an escape
mutant virus ‘reverts’ to the wild-type phenotype, for exam-
ple after transmission to MHC I mismatched new hosts
[34–36]. Depending on the timing of wild-type virus
emergence, it has a higher or lower probability of survival. If
it arises early and expands sufficiently during the period of
high target cell availability, then it will not be lost during the
contraction phase of virus infection [34]. However, the
Fig. 3. Numbers of N-linked glycosylation (PNLG) sites within env V1-V2 regions by comparison of the average PNLG site numbers in
clade A, B and C sequences. Stars indicate statistical difference between clade C with clade A (loss PNLG, P=0.0012; gain PNLG
P=0.0001) and clade B (loss PNLG, P=0.0004; gain PNLG, P=0.0001) (a, b), and between clade A with clade B (gain PNLG, P=0.0472),
respectively (b). K158N mutation was absent in proviral DNA from PBMC at week 2 as compared week 170 p.i. (P=0.0475) (c). M4 ani-
mals had PBMC viral sequences at week 170 p.i. with a statistical different gain of PNLG sites as compared to M1 (P=0.0018), M3
(P=0.0002), M7 (P=0.0004) animals (d).
Table 3. Mean pairwise distances between DNA SHIVSF162P4cy variants
in monkeys with different haplotypes
Mean distance (SE)
Haplotype With SHIVSF162P4cy Within the same haplotype
M1 0.070 (S.E., 0.011) 0.108 (S.E., 0.016)
M3 0.183 (S.E., 0.024) 0.183 (S.E., 0.023)
M4 0.033 (S.E., 0.011) 0.059 (S.E., 0.007)
M7 0.023 (S.E., 0.012) 0.040 (S.E., 0.005)
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presence of these mutations was not associated with neither
an increase in viral load nor disease progression. The selec-
tive advantage of these mutations may represent a virus bet-
ter adapted to the host and, in turn, less pathogenic to
cynomolgus monkeys. This is the case for the nonpatho-
genic molecular clone SHIVSF162Pc, which contains muta-
tions associated with the SHIVSF162P3env 120gp that have
been described in earlier work [37]. In fact, it appears that
in cynomolgus monkeys the long-term persistent infection
with SIV or SHIV relies on host responses, with immune
pressure-driven sequence changes leading to the emergence
of less pathogenic viruses [37]. In this, the effect of protec-
tive MHC genotypes is widely considered a major determi-
nant of viral control and has been shown to significantly
influence the outcome of HIV/SIV infection in their respec-
tive hosts [38–40].
Data presented from MHC heterozygous M3 macaques
indicated that env V1-V2 proviral DNA during the early
and the long-term phase of infection harboured similar
sequences, showing the same high levels of viral diversity
and a signature in tissues. Since the M1 and M3 haplotypes
share MHC class I A alleles, it is possible that in M1/M3
animals the different and more numerous MHC class I B
alleles encoded on each haplotype drive virus diversity. In
these macaques as the virus diversified, convergent changes
occurred in specific residues within V1-V2 region from
independent animals, such as that at the predicted glycosyl-
ation site at position 158. We did not observe any particular
MHC haplotypes associated with the long-term control of
infection, however, we determined a remarkably similar pat-
tern of intra-host viral diversity within heterozygous M3
haplotype. This has also been described by others in M3
haplotype animals [40] that identified M3-restricted CD8+
T cell epitopes selecting for high-frequency mutation in
chronic infection [18, 39, 40]. This suggested that in hetero-
zygous animals bearing the same MHC haplotype and
infected with the same virus, viral diversity could follow a
similar pattern in animals with similar outcome. Our results
reveal that in a setting of natural suppression of viral repli-
cation, controllers do not form a homogeneous group,
because of high genetic variation in the proviral
compartment.
METHODS
Animals and infections
Male adult cynomolgus macaques imported from Mauritius
were housed according to the European guidelines for non-
human primate care (EEC, Directive No. 86–609, 24
November 1986). The study protocol was approved by the
ethics committee of the Istituto Superiore di Sanita. Animals
were clinically examined under ketamine hydrochloride
anaesthesia (10mg kg 1). Macaques used in this study were
part of different experimental protocols as naıve or control
animals [20, 21]. Animals were inoculated intrarectally with
the same SHIVSF162P4cy virus stock as previously described
[20].
Sample collection, plasma viral load and proviral
DNA measurement
Blood was collected throughout the infection and at the
time of euthanasia. Tissue was collected, cut into fragments
and stored at  80

C. DNA was extracted from five distinct
fragments of each tissue using DNeasy Blood and Tissue Kit
(QIAGEN, Italy). To avoid sample cross-contamination,
nucleic acid extractions were performed using cleaning pre-
cautions and separate storage of templates and reagents.
Plasma viremia was detected as previously described by
using a ‘one step’ quantitative reverse transcriptase (RT)-
PCR (TaqMan) assay with a threshold limit for detection of
50 RNA eq ml 1 [20]. To determine proviral load, DNA
was extracted from 400 µl of whole citrated blood by using
the QIamp DNA Blood Mini Kit (QIAGEN, Italy). Tissues
from axillary and inguinal lymph nodes, spleen, jejunum,
ileum, epididymis, testis, prostate, penis and rectum were
processed and total DNA was extracted from five different
fragments of tissue using the DNeasy Blood and Tissue Kit
according to the manufacturer’s instructions. Proviral DNA
copies were quantitated using the TaqMan real-time PCR
with a threshold limit of detection of 1 copy g 1 DNA.
SIVmac251 plasmids were used as standards to calculate
SIV DNA copy numbers. Probe and primers specifically
amplifying a region of 71 bp within the gag sequence of SIV-
mac251 (GI:334657) were designed and thermal cycling
conditions were used as previously described [20, 21]. Sam-
ples were analysed in duplicate and positive and negative
controls were used to rule out sample contamination.
PCR AND SEQUENCING
Viral DNA levels in tissues of some animals were extremely
low. To ensure that the V1-V2 env regions were representa-
tive of the virus populations present in each compartment,
all specimens were subjected to DNA limiting dilution
(<1 template copy per reaction) and endpoint concentra-
tions of template DNA measured such that nested PCR
resulted in <50% of positive reactions [41].
The first round of PCR was performed in 25 µl of (High
Fidelity DNA polymerase PCR master mix Invitrogen). First
round primers: (HXB2 position 6203–6222)-RP27 (5¢GAA
AGA GCA GAA GAC AGT GG) 7523–7542 LD2R (5¢AAT
GTA TGC CCC TCC CAT CA), second-round primers:
(HXB2 position 6592–6606) LD4 (5¢CCC CAC TCT GTG
TTA CTC) 7175–7158 LD9 (5¢AAA TGC TTT CCC CGG
TCC) amplifying a 583 bp fragment encompassing the V1-
V2 env region of SHIVSF162P4cy.
First round PCR amplification conditions: 94

C for 12m
and 35 cycles of 94

C for 90 s, 60

C for 90 s and 72

C for
120 s, ending with an extension step at 72

C for 10m. A 5 µl
aliquot of first-round PCR product was used in the second
round in 25 µl of PCR master mix for 40 cycles. PCR prod-
ucts were analysed by gel electrophoresis, purified and
directly sequenced.
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For sequencing of the SHIVSF162P4cy, VI-V2 env region was
amplified from 500 µl of inoculum using a QIAmp viral
RNA Kit (Qiagen) followed by RT with Superscript III RT
(Invitrogen) according to the manufacturer’s instructions
with reverse primer 5¢ TTG GCC TCA CTG ATA CCC CT.
To ensure amplification of a single viral envelope sequence
representative of the virus populations, synthesized cDNA
was titrated to a single copy, where PCR-positive wells con-
stitute about 30% of the reactions. At this dilution, most
positive wells would contain amplicons derived from a sin-
gle cDNA molecule. For nested PCR: first-round primers:
(HXB2 position 6203–6222-RP27) (5¢GAA AGA GCA
GAA GAC AGT GG) 7523–7542 LD2R (5¢AAT GTA TGC
CCC TCC CAT CA), second-round primers: (HXB2 posi-
tion 6592–6606 LD4) (5¢CCC CAC TCT GTG TTA CTC)
7175–7158 LD9 (5¢AAA TGC TTT CCC CGG TCC). First-
round PCR amplification conditions: 95

C for 12m and 35
cycles of 95

C for 90 s, 60

C for 90 s and 72

C for 120 s and
ending with an extension step at 72

C for 10m. A 5 µl ali-
quot of first-round PCR product was used in the second
round in 25 µl of PCR master mix for 40 cycles. Thirty two
env sequences were derived from the challenge virus stock
and directly sequenced. Chromatograms with dual or
ambiguous peaks were excluded from the analysis. The
mean genetic distance within the V1-V2 env regions of the
challenge virus was 0.002%, which is consistent with the
env diversity estimated for SHIVSF162 [42, 43].
Microsatellite analysis and allele-specific PCR
MHC class IA and IB and class II haplotypes were deter-
mined by microsatellite PCR with resolution of recombi-
nant class IB haplotypes by allele-specific PCR as previously
described [17].
Neutralization assay, anti-Env binding antibodies
and flow cytometry
Plasma nAbs were assessed using a viral infectivity assay
based on TZM-bl cells infected with the SHIVSF162P4cy [20,
21]. Percent neutralization was calculated relative to the
negative control infection, containing pre-challenge plasma
of the same monkey. Neutralizing Ab titres were estimated
as the reciprocal plasma dilution resulting in 50% inhibition
of infection (ID50).
Enzyme-linked immunosorbent assay (ELISA) plates were
coated with an oligomeric, SF162 strain-derived Env protein
and the assay performed as previously reported [20, 21].
Env-specific IgG bAb titres were calculated as the reciprocal
plasma dilution giving optical density (OD) readings three
standard deviations (SD) above negative control, normal
MCM plasma samples [20, 21].
PBMC were stained with anti-CD4 and anti-CD8 mAb
(Becton-Dickinson, USA), and analysed with a FACScan
cytometer as described previously [20, 21].
Phylogenetic analysis
V1-V2 env sequences collected from 13 monkeys and the
SHIVSF162P4cy inoculum were used for phylogenetic analysis.
SHIV(sf162p4) GenBank: JN205735 was used as reference
genome. Multiple sequence alignments were obtained with
Bioedit v 7.[44] followed by manual editing. The NJ phyloge-
netic tree was generated with the LogDet model, calculations
were performed with PAUP* software version 4.0, according
to Swofford and Sullivan (Swofford and Sullivan)-[45].
Statistical support for specific clades was obtained by boot-
strapping values (1000 replicates) and bootstrap values>75%
were considered statistically supported.
The software MEGA 6 [46] allowed the calculation of the
genetic distances from the parental clone and between the
different tissue compartments, by using the LogDet model.
The evaluation of the mutational pattern of the sequences
with respect to the sequence of the inoculum SHIVSF162P4cy
was performed on the alignment obtained with Bioedit. The
evaluation of the N-linked glycosylation sites’ variation was
performed by using the server N-GlycoSite under the HIV
sequence database by using the obtained alignment [28].
Migration analysis was conducted with the Mac Clade v. 4
program to test the viral in/out gene flows among the distinct
compartments (tissues) using a modified version of the Slat-
kin and Maddison test as already described [47]. Specifically,
gene flow analysis was performed classifying the V1-V2 env
sequences into different groups, based on the specific com-
partments from which the sequences were sampled. A one-
character data matrix was obtained by assigning to each
taxon in the tree a one-letter code indicating its group of ori-
gin. The putative origin of each ancestral sequence (i.e. inter-
nal node) in the tree was inferred by finding the most
parsimonious reconstruction of the ancestral character. The
final tree-length, i.e. the number of observed migrations in
the genealogy, was compared to the tree-length distribution
of 10 000 trees, after random joining-splitting.
The numbers of PNLGs in the V1-V2 sequence were deter-
mined by using the tool at https://www.hiv.lanl.gov/con-
tent/sequence/GLYCOSITE/glycosite.html.
Statistical methods
Statistical tests were performed using Graph Pad Prism soft-
ware. The nonparametric Mann–Whitney test was used to
determine P-values when comparing two groups that were
not normally distributed. After controlling for normal dis-
tribution, groups of animals were segregated on the basis of
MHC haplotypes and mean viral load, proviral DNA and
CD4+ T cell count were compared between groups by two-
way ANOVA using Tukey’s multiple comparison test. To
determine the relationship among virological, immunologi-
cal and MHC haplotypes during infection, the analysis of
variance, in which all haplotypes were adjusted for each
other in a multivariate model, was applied. All statistical
tests were carried out at a two-sided 5% significance level.
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